Last Updated on March 2, 2024 by The Health Master
Drugs and Cosmetics Act
The recent Supreme Court ruling has brought into focus a case under the Drugs and Cosmetics Act, 1940, where a fine of Rupees One Lakh was affirmed, but the imprisonment order on a doctor was set aside.
Delving into the intricacies of the legal proceedings, this article explores the court’s rationale, emphasizing the nuances of intent and the implications of Section 18(c) of the Act.
The Judicial Bench: Justice Served
The esteemed Bench, comprising Justice B.R. Gavai and Justice Sanjay Karol, provided insights into their decision, emphasizing that imposing a sentence of imprisonment would be unjustified, particularly in the absence of proven intent to sell or distribute under Section 18(c) of the Act.
Legal Advocacy: Voices in the Courtroom
Senior Advocate S. Nagamuthu represented the Appellant, while Senior Advocate Joseph Aristotle stood for the State.
Understanding their arguments and the dynamics of legal representation sheds light on the complexity of the case.
A Glimpse into the Legal Landscape: High Court’s Upheld Decision
The appeal stemmed from the High Court, which upheld the decision of the Additional District & Sessions Judge.
Analyzing the modifications made by the lower Appellate Court to the Chief Judicial Magistrate‘s order provides a crucial backdrop to the Supreme Court’s final judgment.
The Origins: Clinic Inspection and Legal Ramifications
The case originated from an inspection of a clinic on October 13, 2015, revealing allopathic medicines without proper documentation.
Unpacking the sequence of events, this section outlines how the prosecution initiated proceedings leading to the appellant’s conviction in the Trial Court.
Legal Tussle: Overturning Convictions and Seeking Justice
The lower Appellate Court overturned the conviction for one offense due to a lack of proof regarding the drugs’ intended sale or distribution.
A closer look at the criminal revision filed by the appellant and its dismissal provides insights into the legal intricacies surrounding perversity or infirmity in court orders.
Legal Code Decoded: Section 18A and Section 28
Examining the specific sections under which the appellant was convicted—Section 18A read with Section 28 of the Drugs and Cosmetics Act—unravels the legal implications related to the disclosure or non-disclosure of the manufacturer’s name.
Understanding the prescribed punishment of six months of simple imprisonment along with a minimum fine sets the stage for the Court’s deliberation.
Precedent Matters: Learning from S. Athilakshmi v. State Rep. by The Drug Inspector
Drawing parallels with the case of S. Athilakshmi v. State Rep. by The Drug Inspector, where a doctor was acquitted for stocking a small amount of drugs, highlights the significance of quantity in determining the gravity of the offense.
Analyzing the court’s stance on the non-disclosure of the manufacturer’s name in the context of public interest is crucial for understanding the decision.
Balancing Justice: Professional Context and Punitive Measures
The Bench, acknowledging the appellant’s profession, questioned the justification of imposing a prison sentence, especially when the intent to sell or distribute was not proven.
Assessing the implications of the court’s modification of the judgment and the set-aside imprisonment sentence provides a holistic view of the judicial reasoning.
Cause Title: Palani v The Tamil Nadu State (2024 INSC 110)
Appearance:
Appellant(s): Senior Advocate S. Nagamuthu and Advocate M. P. Parthiban
Respondent(s): Senior Advocate Joseph Aristotle and Advocates D. Kumanan, Deepa. S and Veshal Tyagi
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Exploring Regulatory Shifts: Nutraceuticals and the Role of CDSCO
Huge quantity of medicines seized at Airport
Regulatory Actions on Indian Pharma Industry and Quality Assurance
Include High-End Medical Devices in NLEM: Panel
Govt Seeks Recalculation from NPPA for Antibiotic Cefuroxime Ceiling Price
Telangana Drug Inspectors Now Eligible to Observe USFDA Inspections
DCA Telangana Cracks Down on Unlicensed Medicine Operations
USFDA approval granted for Isosorbide Mononitrate ER Tablets
Unlocking the Potential: E-Pharmacy and the Future of Indian Healthcare
DCA cancels Mylan’s permission to manufacture Alprazolam: Telangana
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: